Cancer therapy developer Artiva Biotherapeutics files to hold IPO on Nasdaq
By Val Kennedy, Artiva Biotherapeutics (ARTV), which is developing cell-based therapies to treat cancer, has filed to hold an initial...
By Val Kennedy, Artiva Biotherapeutics (ARTV), which is developing cell-based therapies to treat cancer, has filed to hold an initial...
From Pitchbook For Fort Ross Ventures, a Silicon Valley firm with strong ties to Russia, the war in Ukraine casts a...
By Renaissance Capital, Alopexx, a Phase 2 biotech developing immune therapies for bacterial, fungal, and parasitic infections, filed on Monday...
By Val Kennedy, Indian e-commerce platform Meesho, which was recently valued at close to $5B, is reportedly eyeing an initial...
By Val Kennedy, Biotech group AN2 Therapeutics (ANTX) has filed to hold an initial public offering to help fund development...
By Joshua Fineman, Talkdesk, a maker of cloud-based call center software, is said to be preparing for a U.S. initial...
By Val Kennedy, Chinese SPAC Jeneration Acquisition (JACAU) has withdrawn plans to hold a US initial public offering to raise...
By Val Kennedy, Peter Thiel-backed German neobank N26 is reportedly eyeing an initial public offering in 2024. N26 Co-Chief Executive...
By Val Kennedy, Mphase Technologies (OTCPK:XDSL) has filed to uplist its shares from the over-the-counter market and raise additional cash through an...
By Renaissance Capital, Heroic Empire Acquisition, a blank check company targeting the biotechnology or TMT industries, filed on Friday with...